{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:18:58Z","timestamp":1778631538815,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007073","name":"University of Mohaghegh Ardabili","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007073","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42417-y","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:37:00Z","timestamp":1774449420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic induction of apoptosis by the epigenetic modulator decitabine and metformin in gastric cancer cells highlights the potential for combination therapy"],"prefix":"10.1038","volume":"16","author":[{"given":"Mohammed","family":"AlAli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeid","family":"Latifi-Navid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Khakzad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"8","key":"42417_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/14728222.2021.1971195","volume":"25","author":"E Abdi","year":"2021","unstructured":"Abdi, E. et al. Emerging therapeutic targets for gastric cancer from a host-Helicobacter pylori interaction perspective. Expert Opin. Ther. Targets 25(8), 685\u2013699 (2021).","journal-title":"Expert Opin. Ther. Targets"},{"issue":"13","key":"42417_CR2","doi-asserted-by":"publisher","first-page":"6114","DOI":"10.1002\/cam4.2497","volume":"8","author":"E Abdi","year":"2019","unstructured":"Abdi, E. et al. Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives. Cancer Med. 8(13), 6114\u20136126 (2019).","journal-title":"Cancer Med."},{"issue":"3","key":"42417_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"42417_CR4","doi-asserted-by":"publisher","first-page":"e70489","DOI":"10.1002\/ctm2.70489","volume":"15","author":"S Latifi-Navid","year":"2025","unstructured":"Latifi-Navid, S. et al. Genetic architecture of gastric adenocarcinoma in West Asia. Clin. Transl Med. 15(10), e70489 (2025).","journal-title":"Clin. Transl Med."},{"key":"42417_CR5","doi-asserted-by":"publisher","first-page":"997633","DOI":"10.3389\/fcell.2022.997633","volume":"10","author":"J Xu","year":"2022","unstructured":"Xu, J. et al. A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers. Front. Cell. Dev. Biol. 10, 997633 (2022).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"4","key":"42417_CR6","first-page":"261","volume":"4","author":"T AZARM","year":"1990","unstructured":"AZARM, T. & GHANNADI, F. Effectiveness of chemotherapy in 54 cases of advanced gastric cancer in Isfahan. Med. J. Islamic Repub. Iran. (MJIRI) 4(4), 261\u2013264 (1990).","journal-title":"Med. J. Islamic Repub. Iran. (MJIRI)"},{"issue":"5","key":"42417_CR7","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00210-023-02781-2","volume":"397","author":"A Sharma","year":"2024","unstructured":"Sharma, A., Jasrotia, S. & Kumar, A. Effects of chemotherapy on the immune system: Implications for cancer treatment and patient outcomes. Naunyn. Schmiedebergs Arch. Pharmacol. 397(5), 2551\u20132566 (2024).","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"issue":"6","key":"42417_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.7150\/ijms.82407","volume":"20","author":"HW Kao","year":"2023","unstructured":"Kao, H. W., Tsai, K. W. & Lin, W. Synergistic effect of metformin and lansoprazole against gastric cancer through growth inhibition. Int. J. Med. Sci. 20(6), 717 (2023).","journal-title":"Int. J. Med. Sci."},{"issue":"7","key":"42417_CR9","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.3390\/ijms25074083","volume":"25","author":"MA Galal","year":"2024","unstructured":"Galal, M. A. et al. Metformin: A dual-role player in cancer treatment and prevention. Int. J. Mol. Sci. 25(7), 4083 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"42417_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2023.12274","volume":"26","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome\u2013refractory anemia by regulating the cell cycle. Experimental Therapeutic Med. 26(6), 1\u201311 (2023).","journal-title":"Experimental Therapeutic Med."},{"issue":"5","key":"42417_CR11","doi-asserted-by":"publisher","first-page":"a026948","DOI":"10.1101\/cshperspect.a026948","volume":"7","author":"T Sato","year":"2017","unstructured":"Sato, T., Issa, J. P. J. & Kropf, P. DNA hypomethylating drugs in cancer therapy. Cold Spring Harbor Perspect. Med. 7(5), a026948 (2017).","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"2","key":"42417_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani, J. A. et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc Netw. 20(2), 167\u2013192 (2022).","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"10294","key":"42417_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian, Y. Y. et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet 398(10294), 27\u201340 (2021).","journal-title":"Lancet"},{"issue":"suppl 5","key":"42417_CR14","doi-asserted-by":"publisher","first-page":"v38","DOI":"10.1093\/annonc\/mdw350","volume":"27","author":"EC Smyth","year":"2016","unstructured":"Smyth, E. C. et al. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 27(suppl 5), v38\u2013v49 (2016).","journal-title":"Ann. Oncol."},{"issue":"3","key":"42417_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","volume":"10","author":"P Fenaux","year":"2009","unstructured":"Fenaux, P. et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol. 10(3), 223\u2013232 (2009).","journal-title":"Lancet Oncol."},{"issue":"6","key":"42417_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/CS20110386","volume":"122","author":"B Viollet","year":"2012","unstructured":"Viollet, B. et al. Cellular and molecular mechanisms of metformin: an overview. Clin. Sci. (Lond). 122(6), 253\u2013270 (2012).","journal-title":"Clin. Sci. (Lond)"},{"issue":"10","key":"42417_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrg.2016.93","volume":"17","author":"PA Jones","year":"2016","unstructured":"Jones, P. A., Issa, J. P. & Baylin, S. Targeting the cancer epigenome for therapy. Nat. Rev. Genet. 17(10), 630\u2013641 (2016).","journal-title":"Nat. Rev. Genet."},{"issue":"7517","key":"42417_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research","year":"2014","unstructured":"Cancer Genome Atlas Research. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513(7517), 202\u2013209 (2014).","journal-title":"Nature"},{"key":"42417_CR19","doi-asserted-by":"publisher","first-page":"813703","DOI":"10.3389\/fphar.2021.813703","volume":"12","author":"MA Rahman","year":"2021","unstructured":"Rahman, M. A. et al. Potential therapeutic action of autophagy in gastric cancer managements: Novel treatment strategies and pharmacological interventions. Front. Pharmacol. 12, 813703 (2021).","journal-title":"Front. Pharmacol."},{"issue":"2","key":"42417_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1053\/j.gastro.2011.04.042","volume":"141","author":"IB Tan","year":"2011","unstructured":"Tan, I. B. et al. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology 141(2), 476\u2013485 (2011).","journal-title":"Gastroenterology"},{"issue":"D1","key":"42417_CR21","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51(D1), D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"42417_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1166\/jbt.2021.2386","volume":"11","author":"S Zheng","year":"2021","unstructured":"Zheng, S. et al. Effect of the BBC3 gene on the proliferation and apoptosis of hepatocellular carcinoma cells through p53-regulated signaling. J. Biomaterials Tissue Eng. 11(1), 135\u2013141 (2021).","journal-title":"J. Biomaterials Tissue Eng."},{"issue":"4","key":"42417_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41419-020-2417-0","volume":"11","author":"ML Hartman","year":"2020","unstructured":"Hartman, M. L. & Czyz, M. BCL-w: Apoptotic and non-apoptotic role in health and disease. Cell Death Dis. 11(4), 260 (2020).","journal-title":"Cell Death Dis."},{"issue":"2","key":"42417_CR24","doi-asserted-by":"publisher","first-page":"a008722","DOI":"10.1101\/cshperspect.a008722","volume":"5","author":"JM Hardwick","year":"2013","unstructured":"Hardwick, J. M. & Soane, L. Multiple functions of BCL-2 family proteins. Cold Spring Harb. Perspect. Biol. 5(2), a008722 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"7","key":"42417_CR25","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/ijc.33698","volume":"149","author":"M Jiang","year":"2021","unstructured":"Jiang, M. et al. Caspase-8: A key protein of cross\u2010talk signal way in PANoptosis in cancer. Int. J. Cancer. 149(7), 1408\u20131420 (2021).","journal-title":"Int. J. Cancer"},{"key":"42417_CR26","doi-asserted-by":"crossref","unstructured":"Thomas, P. D. The gene ontology and the meaning of biological function. In The Gene Ontology Handbook 15\u201324 (2017).","DOI":"10.1007\/978-1-4939-3743-1_2"},{"issue":"D1","key":"42417_CR27","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M. et al. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"42417_CR28","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51(D1), D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"42417_CR29","doi-asserted-by":"crossref","unstructured":"Nguyen, J. et al. Phase I Trial of 5-aza-4\u2019-thio-2\u2019-deoxycytidine (Aza-TdC) in Patients with Advanced Solid Tumors (Wolters Kluwer Health, 2021).","DOI":"10.1200\/JCO.2021.39.15_suppl.3088"},{"key":"42417_CR30","doi-asserted-by":"publisher","first-page":"729485","DOI":"10.3389\/fcell.2021.729485","volume":"9","author":"T Tong","year":"2022","unstructured":"Tong, T. et al. Prognostic autophagy-related model revealed by integrating single-cell RNA sequencing data and bulk gene profiles in gastric cancer. Front. Cell. Dev. Biology. 9, 729485 (2022).","journal-title":"Front. Cell. Dev. Biology"},{"issue":"22","key":"42417_CR31","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1111\/febs.13515","volume":"282","author":"BE Fitzwalter","year":"2015","unstructured":"Fitzwalter, B. E. & Thorburn, A. Recent insights into cell death and autophagy. FEBS J. 282(22), 4279\u20134288 (2015).","journal-title":"FEBS J."},{"key":"42417_CR32","doi-asserted-by":"publisher","first-page":"620641","DOI":"10.3389\/fonc.2020.620641","volume":"10","author":"E Cuyas","year":"2020","unstructured":"Cuyas, E. et al. Metformin: Targeting the metabolo-epigenetic link in cancer biology. Front. Oncol. 10, 620641 (2020).","journal-title":"Front. Oncol."},{"issue":"4","key":"42417_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10059-013-0169-8","volume":"36","author":"YK Choi","year":"2013","unstructured":"Choi, Y. K. & Park, K. G. Metabolic roles of AMPK and metformin in cancer cells. Mol. Cells. 36(4), 279\u2013287 (2013).","journal-title":"Mol. Cells"},{"issue":"1","key":"42417_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","volume":"5","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Overcoming cancer therapeutic bottleneck by drug repurposing. Signal. Transduct. Target. Ther. 5(1), 113 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"42417_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ijc.23607","volume":"123","author":"C Stresemann","year":"2008","unstructured":"Stresemann, C. & Lyko, F. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int. J. Cancer. 123(1), 8\u201313 (2008).","journal-title":"Int. J. Cancer."},{"issue":"26","key":"42417_CR36","doi-asserted-by":"publisher","first-page":"22531","DOI":"10.1021\/acsomega.2c01820","volume":"7","author":"C Nayak","year":"2022","unstructured":"Nayak, C. & Singh, S. K. Integrated transcriptome profiling identifies prognostic hub genes as therapeutic targets of glioblastoma: evidenced by bioinformatics analysis. ACS omega. 7(26), 22531\u201322550 (2022).","journal-title":"ACS omega"},{"issue":"1","key":"42417_CR37","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1038\/s41598-018-23395-2","volume":"8","author":"A Tomczak","year":"2018","unstructured":"Tomczak, A. et al. Interpretation of biological experiments changes with evolution of the Gene Ontology and its annotations. Sci. Rep. 8(1), 5115 (2018).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42417-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42417-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42417-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:46:38Z","timestamp":1778629598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42417-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42417"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42417-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7382082\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was performed according to the ethical principles for human research declared in the 1975 Declaration of Helsinki. This study was approved by the Ethics Committee of the University of Mohaghegh Ardabili\/IR.UMA.REC.1404.037 (webpage of ethical approval code is:\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14951"}}